Cormorant Asset Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88M | Hold |
|
|||||
|
2025
Q1 | $1.69M | Hold |
|
|||||
|
2024
Q4 | $2.8M | Sell |
|
|||||
|
2024
Q3 | $5.25M | Hold |
|
|||||
|
2024
Q2 | $5.77M | Hold |
|
|||||
|
2024
Q1 | $5.77M | Sell |
|
|||||
|
2023
Q4 | $5.72M | Hold |
|
|||||
|
2023
Q3 | $4.29M | Hold |
|
|||||
|
2023
Q2 | $11.6M | Hold |
|
|||||
|
2023
Q1 | $9.06M | Hold |
|
|||||
|
2022
Q4 | $10M | Hold |
|
|||||
|
2022
Q3 | $14M | Hold |
|
|||||
|
2022
Q2 | $14.4M | Hold |
|
|||||
|
2022
Q1 | $22.9M | Sell |
|
|||||
|
2021
Q4 | $28.4M | Sell |
|
|||||
|
2021
Q3 | $32.5M | Hold |
|
|||||
|
2021
Q2 | $43M | Sell |
|
|||||
|
2021
Q1 | $55.8M | Hold |
|
|||||
|
2020
Q4 | $89M | Sell |
|
|||||
|
2020
Q3 | $51.5M | Sell |
|
|||||
|
2020
Q2 | $40.5M | Sell |
|
|||||
|
2020
Q1 | $39.2M | Sell |
|
|||||
|
2019
Q4 | $50.7M | Buy |
|
|||||
|
2019
Q3 | $38.4M | Sell |
|
|||||
|
2019
Q2 | $54.5M | Buy |
|